HOUT-22. EVALUATING CLINICAL IMPACT UTILIZING THE RANO-PRO COLLABORATIVEâS STANDARDIZED PRIORITY CONSTRUCTS
- 期刊名称Neuro-Oncology
- 作者Vera, Elizabeth; Gilbert, Mark; Aboud, Orwa; Antony, Ramya; Boris, Lisa; Bryla, Christine; Burton, Eric; Cordova, Christine; Crandon, Sonja; Leggiero, Nicole; Penas-Prado, Marta; Reyes, Jennifer; Siegel, Christine; Theeler, Brett; Wall, Kathleen; Wu, Jing; Armstrong, Terri
- 卷第21卷
- 印刷ISSN1522-8517
- 电子ISSN1523-5866
- 文件大小86.94KB
- 发表时间2019-11-11
- DOI10.1093/neuonc/noz175.487
同期刊推荐
Editorial: Introducing NAR CancerDynan, William S · NAR Cancer · 2019
Combined cytotoxic chemotherapy and immunotherapy of cancer: modern timesBailly, Christian; Thuru, Xavier; Quesnel, Bruno · NAR Cancer · 2020
The role of Sp1 in the detection and elimination of cells with persistent DNA strand breaksLoshchenova, Polina S; Sergeeva, Svetlana V; Fletcher, Sally C; Dianov, Grigory L · NAR Cancer · 2020
Putatively cancer-specific exonâexon junctions are shared across patients and present in developmental and other non-cancer cellsDavid, Julianne K; Maden, Sean K; Weeder, Benjamin R; Thompson, Reid F; Nellore, Abhinav · NAR Cancer · 2020